Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine - 22/08/11
Boston, Massachusetts, USA
Abstract |
Background |
Random biopsy esophageal surveillance can be subject to sampling errors, resulting in diagnostic uncertainty. Optical frequency domain imaging (OFDI) is a high-speed, 3-dimensional endoscopic microscopy technique. When deployed through a balloon-centering catheter, OFDI can automatically image the entire distal esophagus (6.0 cm length) in approximately 2 minutes.
Objective |
To test a new platform for guided biopsy that allows the operator to select target regions of interest on an OFDI dataset, and then use a laser to mark the esophagus at corresponding locations. The specific goals include determining the optimal laser parameters, testing the accuracy of the laser marking process, evaluating the endoscopic visibility of the laser marks, and assessing the amount of mucosal damage produced by the laser.
Design |
Experimental study conducted in 5 swine in vivo.
Setting |
Massachusetts General Hospital.
Main Outcome Measurements |
Success rate, including endoscopic visibility of laser marks and accuracy of the laser marking process for selected target sites, and extent of the thermal damage caused by the laser marks.
Results |
All of the laser-induced marks were visible by endoscopy. Target locations were correctly marked with a success rate of 97.07% (95% confidence interval, 89.8%-99.7%). Thermal damage was limited to the superficial layers of the mucosa and was observed to partially heal within 2 days.
Limitations |
An animal study with artificially placed targets to simulate pathology.
Conclusions |
The study demonstrates that laser marking of esophageal sites identified in comprehensive OFDI datasets is feasible and can be performed with sufficient accuracy, precision, and visibility to guide biopsy in vivo.
Le texte complet de cet article est disponible en PDF.Abbreviations : OFDI, OCT
Plan
| DISCLOSURE: Brett E. Bouma and Guillermo J. Tearney received a research grant from theOlympus Corporation. All other authors disclosed no financial relationships relevant to this publication. |
|
| If you would like to chat with an author of this article, you may contact Dr. Suter at msuter@partners.org. |
Vol 71 - N° 2
P. 346-353 - février 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
